5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | NEUTRAL | BUY | NEUTRAL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.62▼ | 2.63▼ | 2.63▼ | 2.54▲ | 2.43▲ |
MA10 | 2.61▲ | 2.63▼ | 2.63▼ | 2.36▲ | 2.42▲ |
MA20 | 2.62▼ | 2.63▼ | 2.65▼ | 2.43▲ | 2.24▲ |
MA50 | 2.63▼ | 2.64▼ | 2.39▲ | 2.42▲ | 4.24▼ |
MA100 | 2.63▼ | 2.37▲ | 2.37▲ | 2.25▲ | 5.96▼ |
MA200 | 2.65▼ | 2.40▲ | 2.50▲ | 3.56▼ | 14.52▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.001▲ | -0.006▼ | -0.021▼ | 0.037▲ | 0.181▲ |
RSI | 43.556▼ | 48.490▼ | 55.570▲ | 55.503▲ | 45.730▼ |
STOCH | 70.278 | 49.585 | 60.338 | 65.309 | 52.085 |
WILL %R | -40.000 | -64.286 | -50.000 | -21.875▲ | -32.143 |
CCI | -19.226 | -99.029 | -52.000 | 89.873 | 46.879 |
CDL | $MRVI Doji Candlestick Pattern Detected | Set Alert |
Wednesday, August 13, 2025 05:23 AM
Q2 2025 Earnings Call Transcript August 11, 2025 Maravai LifeSciences Holdings, Inc. misses on earnings expectations. Reported EPS is $-0.08 EPS, expectations were $-0.06. Operator: Good afternoon, ...
|
Wednesday, August 13, 2025 04:45 AM
NasdaqGS:MRVI 1 Year Share Price vs Fair Value Explore Maravai LifeSciences Holdings's Fair Values from the ...
|
Monday, August 11, 2025 08:36 PM
Discover Maravai LifeSciences' Q2 2025 earnings insights: restructuring plans, cost-cutting moves saving $50M+, and a roadmap to profitability by 2026.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 2.605 | 2.66 | 2.59 | 2.615 | 720,913 |
14/08/25 | 2.69 | 2.69 | 2.56 | 2.60 | 1,051,409 |
13/08/25 | 2.68 | 2.79 | 2.63 | 2.75 | 1,568,598 |
12/08/25 | 2.33 | 2.70 | 2.30 | 2.69 | 4,997,269 |
11/08/25 | 2.22 | 2.255 | 2.025 | 2.06 | 1,732,121 |
08/08/25 | 2.06 | 2.21 | 2.025 | 2.20 | 1,583,642 |
07/08/25 | 2.04 | 2.06 | 1.99 | 2.025 | 3,268,014 |
06/08/25 | 2.33 | 2.36 | 2.03 | 2.035 | 2,223,151 |
05/08/25 | 2.26 | 2.40 | 2.23 | 2.34 | 1,405,235 |
04/08/25 | 2.23 | 2.30 | 2.18 | 2.27 | 1,728,391 |
|
|
||||
|
|
||||
|
|